UROLITHIASIS AMONG HIV INFECTED PATIENTS IN THE HIGHLY ACTIVE ANTI-RETROVIRAL THERAPY (HAART) ERA

被引：0
|
作者：
Mirheydar, Hossein
Raheem, Omer
Palazzi-Churas, Kerrin
Chenoweth, Marianne
Lakin, Charles M.
Sur, Roger L.
机构：
来源：
JOURNAL OF UROLOGY | 2012年 / 187卷 / 04期
关键词：
D O I：
10.1016/j.juro.2012.02.2427
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
2250
引用
收藏
页码：E907 / E908
页数：2
相关论文
共 50 条
  • [41] Left ventricular dysfunction in HIV infected anti-retroviral therapy naive patients
    Mystakelis, C.
    Lisco, A.
    Manion, M.
    Rupert, A.
    Roby, G.
    Sheikh, V.
    Sereti, I.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 433 - 433
  • [42] Predictors of death in Malaysian HIV-infected patients on anti-retroviral therapy
    Lubis, Rahayu
    Bulgiba, Awang
    Kamarulzaman, Adeeba
    Hairi, Noran N.
    Dahlui, Maznah
    Peramalah, Devi
    PREVENTIVE MEDICINE, 2013, 57 : S54 - S56
  • [43] Psychological distress and adherence to highly active anti-retroviral therapy (HAART) in Uganda: A pilot study.
    Nakimuli-Mpungu, Etheldreda
    Mutamba, Brian
    Othengo, Makanga
    Musisi, Seggane
    AFRICAN HEALTH SCIENCES, 2009, 9 : S2 - S7
  • [44] Diabetes Mellitus and Associated Factors Among Adult HIV Patients on Highly Active Anti-Retroviral Treatment
    Duguma, Fanta
    Gebisa, Waqtola
    Mamo, Aklilu
    Tamiru, Dessalegn
    Woyesa, Shiferaw
    HIV AIDS-RESEARCH AND PALLIATIVE CARE, 2020, 12 : 657 - 665
  • [45] Highly Active Anti-Retroviral Therapy (Haart) Induced Hepatic Steatosis And Injury Is Markedly Enhanced By Ethanol
    Donde, Hridgandh
    Ghare, Smita
    Zhang, Jingwen
    Kirpich, Irina
    Joshi-Barve, Swati
    Gobejishvili, Leila
    McClain, Craig J.
    Barve, Shirish
    HEPATOLOGY, 2013, 58 : 537A - 537A
  • [46] Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma
    Bower, M
    Fox, P
    Fife, K
    Gill, J
    Nelson, M
    Gazzard, B
    AIDS, 1999, 13 (15) : 2105 - 2111
  • [47] Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy
    Mark E. Sharkey
    Ian Teo
    Thomas Greenough
    Natalia Sharova
    Katherine Luzuriaga
    John L. Sullivan
    R. Pat Bucy
    Leondios G. Kostrikis
    Ashley Haase
    Claire Veryard
    Raul E. Davaro
    Sarah H. Cheeseman
    Jennifer S. Daly
    Carol Bova
    Richard T. Ellison
    Brian Mady
    Kwan Kew Lai
    Graeme Moyle
    Mark Nelson
    Brian Gazzard
    Sunil Shaunak
    Mario Stevenson
    Nature Medicine, 2000, 6 : 76 - 81
  • [48] Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy
    Sharkey, ME
    Teo, I
    Greenough, T
    Sharova, N
    Luzuriaga, K
    Sullivan, JL
    Bucy, RP
    Kostrikis, LG
    Haase, A
    Veryard, C
    Davaro, RE
    Cheeseman, SH
    Daly, JS
    Bova, C
    Ellison, RT
    Mady, B
    Lai, KK
    Moyle, G
    Nelson, M
    Gazzard, B
    Shaunak, S
    Stevenson, M
    NATURE MEDICINE, 2000, 6 (01) : 76 - 81
  • [49] Reduced morbidity and mortality in the first year after initiating highly active anti-retroviral therapy (HAART) among Ugandan adults
    Miiro, George
    Todd, Jim
    Mpendo, Juliet
    Watera, Christine
    Munderi, Paula
    Nakubulwa, Susan
    Kaddu, Ismael
    Rutebarika, Diana
    Grosskurth, Heiner
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2009, 14 (05) : 556 - 563
  • [50] Highly Active Anti-Retroviral Treatment (HAART) Medication Adherence in Adolescents with Perinatally-Acquired HIV Infection
    Sporter, R. J.
    Meyer, E. A.
    Rosenthal, D. W.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (02) : AB78 - AB78
12345